What is it about?

This is a review article on the specifics of coronary artery disease in patients with systemic inflammatory disease, specifically in patients with systemic lupus atheromatous. We analyzed the relationship between systemic lupus erythematosus and cardiovascular diseases, with the emphasis on acute myocardial infarction. We conducted a literature review through PubMed and Cochrane, using keywords: SLE, atherosclerosis, atherothrombosis, coronary artery disease, myocardial infarction, prognosis, sex specifics. Results. Various molecular mechanisms triggered by infection/inflammation are responsible for endothelial dysfunction and the development of atherosclerosis at an earlier age. Contributing factor is the cumulative effect of traditional cardiovascular risk factors interacting with disease-related characteristics. Myocardial infarction rates are 2- to 10-fold higher compared to the general population. Young women have the highest relative risk, however, men carry at least 3- fold higher risk than women. Coronary involvement varies from normal coronary artery with thrombosis, coronary microartery vasculitis, coronary arteritis, and coronary atherosclerosis. Typical clinical presentation is observed in men and older women, while atypical is more frequent in young women. Treatment is guided by the underlying mechanism, engaging invasive procedures alone, or accompanied with immunosuppressive and/or anti-inflammatory therapy. There are significant gender differences in pathophysiology and clinical presentation. However, they receive the same therapeutic treatments. Conclusion. Systemic lupus erythematosus is a major contributor to atherosclerotic and non- atherosclerotic mechanisms involved in the development of myocardial infarction, which should be taken into account during therapeutic treatment. Although Systemic lupus erythematosus per se is a “female” disease, males are at increased cardiovascular risk and have worse outcomes.

Featured Image

Why is it important?

This is one of the rare reviews on the topic of myocardial infarction in patients with systemic lupus erythematosus, even though we know that this is a highly prevalent disease, especially among the female population.

Read the Original

This page is a summary of: Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile, Current Pharmaceutical Design, September 2021, Bentham Science Publishers,
DOI: 10.2174/1381612826666201210110809.
You can read the full text:

Read

Contributors

The following have contributed to this page